EHA 2018 | Follicular lymphoma: is RELEVANCE relevant?

Franck Morschhauser

Dr Franck Morschhauser, of Centre Hospitalier Universitaire Régional de Lille, Unité GRITA, Lille, France, discusses the question: is RELEVANCE relevant? He covers the results of the Phase III study (NCT01476787) of R2 vs R-chemo in first-line follicular lymphoma. This video was recorded at the 23rd congress of the European Hematology Association (EHA) 2018 press briefing, held in Stockholm, Sweden.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter